Table 3 Duration of sirolimus therapy and dosage
From: A retrospective review of oral low-dose sirolimus (rapamycin) for the treatment of active uveitis
Case | Duration of therapy (weeks) | Initial dose (mg) | Final dose (mg) | Weight (kg) | Number of flares | Still taking | Side effects |
|---|---|---|---|---|---|---|---|
1 | 65 | 2 | 2 | 95 | 0 | Yes | No significant side effects to date |
2 | 50 | 3 | 4 | 122 | 1 | Yes | No significant side effects to date |
3 | 42 | 2 | 4 | 86 | 1 | Yes | No significant side effects to date |
4 | 21 | 3 | 3 | 102 | 0 | Yes | No significant side effects to date |
5 | 8 | 2 | 3 | 79 | 1 | No | DVT-left popliteal |
6 | 6 | 2 | 2 | 72 | 0 | No | Nausea, vomiting, recurrence of aseptic meningitis |
7 | 4 | 2 | 2 | 64 | 0 | No | Thrombocytopenia |
8 | 2 | 2 | 2 | 80 | No data | No | No data |